Prognostic value of volume-based metabolic parameters of [18F]FDG PET/CT in anaplastic thyroid carcinoma
European Journal of Nuclear Medicine and Molecular Imaging · 2026
DOI: 10.1007/s00259-026-08100-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von H I Coerts und 13 weiteren Autor:innen. Beteiligte Einrichtung: Academic Center for Thyroid Diseases, Department of Radiology and Nuclear Medicine, Erasmus Medical Centre Rotterdam, P.O. 2040, Doctor Molewaterplei…. Hauptthemen laut MEDLINE: Thyroid Carcinoma, Anaplastic, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Tumor Burden. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KWF Kankerbestrijding.
Abstract (Originalsprache)
Introduction
Anaplastic thyroid carcinoma (ATC) is a rare and aggressive malignancy with a median overall survival (OS) of approximately 2 months. The prognostic value of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography ([ 18 F]FDG PET/CT) in ATC remains unclear. This study aims to evaluate the prognostic significance of [ 18 F]FDG PET/CT parameters in ATC patients.
Methods
This retrospective study analyzed 34 patients diagnosed with ATC between January 2010 and October 2024 who underwent initial staging with [ 18 F]FDG PET/CT. Data collected included standardized uptake value (SUV), metabolic tumor volume (MTV), and total lesion glycolysis (TLG), along with patient and tumor characteristics. The relationships between these parameters and survival were assessed.
Results
OS was 48 days (IQR: 27–134). In univariate analysis, MTV (HR = 1.44, p = 0.009) was significantly associated with poorer OS. Surgery was associated with a significantly decreased hazard of mortality (HR, 0.418; 95% CI, 0.188–0.929; P = 0.032), as was radiotherapy (HR, 0.423; 95% CI, 0.220–0.977; P = 0.026).
Conclusion
This study identifies MTV as a significant prognostic markers in univariate analysis for patients with ATC, highlighting the utility of [ 18 F]FDG PET/CT in predicting patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Academic Center for Thyroid Diseases, Department of Radiology and Nuclear Medicine, Erasmus Medical Centre Rotterdam, P.O. 2040, Doctor Molewaterplein 40, 3015 GD , CA, 3000, Rotterdam, the Netherlands.
- Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Groningen, 9713 GZ, The Netherlands.
- Department of Internal Medicine, Division of Endocrinology, Radboud University Nijmegen Medical Center, PO Box 9101, Nijmegen, 6500HB, the Netherlands.
- Division of Endocrinology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
- Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
- Academic Center for Thyroid Diseases, Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Förderung
- KWF Kankerbestrijding
Zitieren
APA
Coerts, H. I., Smit, O. P., Lin, J. F., van Houten, P., Links, T. P., Brouwers, A. H., van der Rijt, C. C. D., van Ginhoven, T. M., Netea-Maier, R. T., van Treijen, M. J. C., Medici, M., de Keizer, B., Kruijff, S., & Verburg, F. A. (2026). Prognostic value of volume-based metabolic parameters of [18F]FDG PET/CT in anaplastic thyroid carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-026-08100-0
Vancouver
Coerts HI, Smit OP, Lin JF, van Houten P, Links TP, Brouwers AH, et al. Prognostic value of volume-based metabolic parameters of [18F]FDG PET/CT in anaplastic thyroid carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-026-08100-0
BibTeX
@article{Coerts2026,
author = {Coerts, H I and Smit, O P and Lin, J F and van Houten, P and Links, T P and Brouwers, A H and van der Rijt, C C D and van Ginhoven, T M and Netea-Maier, R T and van Treijen, M J C and Medici, M and de Keizer, B and Kruijff, S and Verburg, F A},
title = {Prognostic value of volume-based metabolic parameters of [18F]FDG PET/CT in anaplastic thyroid carcinoma},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
doi = {10.1007/s00259-026-08100-0}
}
EUVIMED